Abbott Laboratories
XMUN:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
Meta Platforms Inc
NASDAQ:META
|
US |
|
E
|
Experian PLC
F:J2B
|
IE |
|
P
|
Paychex Inc
XHAM:PCX
|
US |
|
AC Immune SA
F:IMR
|
CH |
|
B
|
Boeing Co
XMUN:BCO
|
US |
|
Schibsted ASA
OSE:SCHA
|
NO |
|
M
|
Meta Platforms Inc
XMUN:FB2A
|
US |
|
P
|
PPG Industries Inc
XMUN:PPQ
|
US |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 106.43 EUR with a low forecast of 90.46 EUR and a high forecast of 124.17 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
106.43
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 106.43 EUR with a low forecast of 90.46 EUR and a high forecast of 124.17 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 16%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
18%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 18%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 17%.
